A 2025 study found that ox-LDL-induced CD36 upregulation in double-negative regulatory T cells precipitates ferroptosis and disrupts hepatic immune homeostasis in MASLD [81]. This evidence concerns the gene CD36 and metabolic dysfunction-associated steatotic liver disease.